Search Results - "Jia, Jinsong"
-
1
Porcine antilymphocyte globulin versus rabbit antithymocyte globulin for intensive immunosuppressive therapy of acquired aplastic anemia: A meta-analysis and systematic review
Published in International journal of clinical pharmacology and therapeutics (01-12-2023)“…Objective: Several studies have reported that porcine antilymphocyte globulin (pALG) has a significant effect on aplastic anemia (AA), but their conclusions…”
Get full text
Journal Article -
2
Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
Published in Frontiers in immunology (11-07-2023)“…Transfusion-dependent non-severe aplastic anemia (TD-NSAA) is a rare condition of bone marrow failure that can persist for a long time or develop into severe…”
Get full text
Journal Article -
3
Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world
Published in Clinical and experimental medicine (01-10-2023)“…Eltrombopag (EPAG) can improve the efficacy of immunosuppressive therapy (IST) consisting of antithymocyte immunoglobulin (ATG) and cyclosporin in severe…”
Get full text
Journal Article -
4
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center
Published in Annals of hematology (01-05-2021)“…Core binding factor acute myeloid leukemia (CBF-AML), including cases with KIT mutation, is currently defined as a low-risk AML. However, some patients have…”
Get full text
Journal Article -
5
Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
Published in Frontiers in immunology (26-05-2022)“…Addition of eltrombopag (E-PAG) to intensive immunosuppressive therapy (IST) contributes to restoring hematopoiesis in patients with severe aplastic anemia…”
Get full text
Journal Article -
6
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth
Published in The Journal of clinical investigation (01-09-2015)“…The regulatory microRNA miR-150 is involved in the development of hemopathies and is downregulated in T-lymphomas, such as anaplastic large-cell lymphoma…”
Get full text
Journal Article -
7
Rapid diagnosis of Aspergillus flavus infection in acute very severe aplastic anemia with metagenomic next-generation sequencing: a case report and literature review
Published in Frontiers in medicine (23-09-2024)“…Infection remains the leading cause of mortality in severe aplastic anemia (SAA) patients, with invasive fungal infections being the great threat. accounts for…”
Get full text
Journal Article -
8
Patients with AML-MRC benefit from decitabine in combination with low-dose G-CSF, cytarabine and aclarubicin: A single center cohort study
Published in Leukemia research reports (01-01-2022)“…Patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) are insensitive to conventional chemotherapy and, therefore, have a poor…”
Get full text
Journal Article -
9
Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial
Published in Cancer medicine (Malden, MA) (01-07-2023)“…Background The hypomethylating agent decitabine is the standard therapy for intermediate or high risk myelodysplastic syndrome (MDS). Methods In this trial,…”
Get full text
Journal Article -
10
-
11
P1555: COVID‑19 INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: A SINGLE‐CENTRE SURVEY DURING THE LATEST OMICRON WAVE IN CHINA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
12
Assessing the efficiency and significance of Methylated DNA Immunoprecipitation (MeDIP) assays in using in vitro methylated genomic DNA
Published in BMC research notes (16-09-2010)“…DNA methylation contributes to the regulation of gene expression during development and cellular differentiation. The recently developed Methylated DNA…”
Get full text
Journal Article -
13
Fractional-order super-twisting sliding mode attitude control for elastic refueling boom with exogenous disturbances
Published in Nonlinear dynamics (01-07-2024)“…During the aerial refueling alignment phase, the slender refueling boom is prone to elastic deformation under random exogenous disturbances, which deteriorates…”
Get full text
Journal Article -
14
Outcome of Standard Immunosuppressive Therapy with or without Eltrombopag for Chinese Patients with Severe Aplastic Anemia in the Real World
Published in Blood (13-11-2019)“…BACKGROUND Immunosuppression is the current standard therapy for patients with severe aplastic anemia(SAA), whereas allogeneic haematopoietic stem cell…”
Get full text
Journal Article -
15
Prolonged Use of Eltrombopag in Patients with Severe Aplastic Anemia without Complete Response at 6 Months after Immunosuppressive Therapy
Published in Blood (15-11-2022)Get full text
Journal Article -
16
A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia
Published in Annals of hematology (01-11-2022)“…Eltrombopag (EPAG), a thrombopoietin receptor agonist, was approved for the treatment of severe aplastic anemia (SAA) combined with immunosuppressive therapy…”
Get full text
Journal Article -
17
Intensive Immunosupressive Therapy Combining with Eltrombopag for Adult Chinese Patients with Severe Aplastic Anemia
Published in Blood (23-11-2021)“…In sight of different pharmacokinetics between races, the recommended dose is 75mg/d for Asian using eltrombopag [1]. However, the efficacy and safety of…”
Get full text
Journal Article -
18
Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study
Published in Blood (02-11-2023)“…Background: Hypomethylating agents (HMAs) are the preferred treatment for untreated patients with higher-risk Myelodysplastic Syndrome (MDS). However, the…”
Get full text
Journal Article -
19
-
20
A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia
Published in Annals of hematology (01-11-2022)“…Eltrombopag (EPAG), a thrombopoietin receptor agonist, was approved for the treatment of severe aplastic anemia (SAA) combined with immunosuppressive therapy…”
Get full text
Journal Article